{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.88G>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "88"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "NM_000345.4:c.136G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "136"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "A",
                        "position": "46"
                    },
                    "Description in input context": "E46K"
                },
                {
                    "HGVS": "NM_000345.4:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Human neuroblastoma M17 cells",
                "Description": "Human neuroblastoma M17 cells were used for the experiments."
            },
            "Readout type": "Quantitative",
            "Readout description": [
              {
                "Variant": "NM_000345.4:c.88G>C",
                "Conclusion": "Abnormal",
                "Molecular Effect": "gain-of-function",
                "Result Description": "A30P mutant a-synuclein exhibited robust resistance to degradation by the proteosome."
              },
              {
                "Variant": "NM_000345.4:c.136G>A",
                "Conclusion": "Normal",
                "Molecular Effect": "No Effect",
                "Result Description": "E46K mutation did not affect a-synuclein degradation significantly in HO-1 over-expressing cells."
              },
              {
                "Variant": "NM_000345.4:c.157G>A",
                "Conclusion": "Normal",
                "Molecular Effect": "No Effect",
                "Result Description": "A53T mutation did not affect a-synuclein degradation significantly in HO-1 over-expressing cells."
              }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Most experiments had biological replicates to meet statistical needs."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "a-Synuclein wild-type (WT) should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "a-Synuclein wild-type (WT) and A30P mutant in pcDNA3 vector(gifts from Dr. A Tandon of the University of Toronto) were subcloned individually into the HindIII and XbaI sites of pcDNA3.1/Zeo."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
              "Statistical analysis method": "ANOVA;Newmanâ€“Keuls post hocparisons"
              
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}